- 19 2019/06
iSCLife® products bring new treatments to pat...
The clinical application known as "Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife®-CSD) for the treatment of uterine traumatic healing failure" with stem cell product has been approved by the state and fully supported by Professor Zhang Weishe, director of the Department of Obstetrics and Gynecology, Xiangya Hospital.
查看详细
-
24 2018/10Be rpoud of China
Be proud of ChinaIn the field of biotechnology, China is developing at a rapid pace. In the field of human mesenchymal stem cells, China is leading the custom international standards. To be precise, China's SCLnow® is the leading international standard. Today, the four great inventions of the new era have made tremendous contributions to China's economic development. C
查看详细 -
23 2018/10Pull double eyelid
iSCL stem cell®Daily | After getting double fold eyelids: Sawadika (Hello)!Yes, it’s me again.Of course, this is just my nickname.The name is iSCL stem cell® !
查看详细 -
22 2018/10Some people are changing the world
Some people are changing the future quietly.The choice of a new eraNo longer let love lingerNo longer let beauty downThe choice of SCLnow®Always cares about you and me
查看详细 - 18 2018/10
Never growing old
“Never growing old” SecretPeople are willing to respect the old and love the old, but no one wants to grow old. SCLnow® often gives others an impression of being young and energetic. The secret to Keep young is iSCLife®
查看详细 -
16 2018/10What to save you
What to save you, my mesenchymal stem cells“Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-LC) for Treatment of Decompensated Hepatitis B Cirrhosis” of SCLnow® and XiangYa Hospital of Central South University's has accomplished registration procedure in accordance with the Stem Cell Clinical Research Management Regulations ( Trial) (National Health S
查看详细